Galderma is committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world.
As a global leader, Galderma offers a wide range of medical solutions to treat dermatological needs at all ages, all stages of life.
We provide an extensive portfolio of prescription, self-medication, and aesthetic and corrective medical solutions available in 70 countries.
Meeting the highest standards of safety and efficacy, our products are developed for a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence.
With approximately 20% of revenues invested each year to discover and develop new products and access innovative technologies, Galderma is one of the world's leading investors in dermatology R&D.